Top 50 Life Science Angel Investors in United States (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Sahin Boydas
Angel
|
8 | United States, Mexico, Norway | Seed, Series A, Series B | Software, Financial Services, Information Technology | $500k–$150M |
|
Milad Alucozai
Angel
|
5 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $110k–$60M |
|
Christopher Gibson
Angel
|
4 | United States, United Kingdom, France | Series A, Seed, Series B | Biotechnology, Health Care, Pharmaceutical | $5.4M–$55M |
|
bumpkins profile
Angel
|
4 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $500k–$57M |
|
Kevin Moore
Angel
|
4 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $190k–$5.2M |
|
Jeff Hammerbacher
Angel
|
3 | United States, Germany | Seed, Series A, Angel | Artificial Intelligence, Software, Biotechnology | $330k–$25M |
|
Chris Gibson
Angel
|
3 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Darian Shirazi
Angel
|
3 | United States, Germany, Canada | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$73M |
|
Sam Altman
Angel
|
3 | United States, Canada, Ghana | Seed, Series A, Series B | Software, Artificial Intelligence, Biotechnology | $1.2M–$100M |
|
Kevin Mahaffey
Angel
|
3 | United States, Canada, Israel | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $1.3M–$30M |
|
Esther Dyson
Angel
|
3 | United States, Canada, Russian Federation | Seed, Series A | Health Care, Software, Medical | $270k–$16M |
|
Erik Peterson
Angel
|
3 | United States, Canada, Algeria | Seed, Equity Crowdfunding, Series A | Software, SaaS, Mobile | $69k–$20M |
|
Zach Weinberg
Angel
|
2 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, Medical | $1.4M–$30M |
|
Alec Nielsen
Angel
|
2 | United States, Germany | Seed, Pre-Seed | Biotechnology, Biopharma, Medical | $3M–$16M |
|
Craig Mundie
Angel
|
2 | United States | Seed, Series B, Series C | Life Science, Chemical, Genetics | |
|
Robin Lingg
Angel
|
2 | United States | Seed | News, Life Science, Machine Learning | $1.5M–$3.5M |
|
John Ballantyne
Angel
|
2 | United States, Singapore | Seed, Series A, Angel | Health Care, Biotechnology, Therapeutics | $4.5M–$30M |
|
Patrick Yang
Angel
|
2 | United States | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.5M–$50M |
|
Sridhar Iyengar
Angel
|
2 | United States | Seed, Angel, Pre-Seed | B2B, Events, Travel | $470k–$3M |
|
Patrick Collison
Angel
|
2 | United States, United Kingdom, Ireland | Series A, Seed, Series C | Software, Artificial Intelligence, Information Technology | $2.7M–$170M |
|
Jay Zaveri
Angel
|
2 | United States, Japan, Canada | Seed, Series A, Series B | Health Care, Biotechnology, Artificial Intelligence | $1M–$6B |
|
Jeff Dean
Angel
|
2 | United States, United Kingdom, Japan | Seed, Series A, Pre-Seed | Artificial Intelligence, Information Technology, Software | $450k–$60M |
|
James Hong
Angel
|
2 | United States | Seed, Series A, Angel | E-Commerce, Mobile, Internet | $100k–$25M |
|
Elad Gil
Angel
|
2 | United States, United Kingdom, Israel | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$117M |
|
Aiden Ross
Angel
|
2 | United States | Seed, Pre-Seed | Consulting, Life Science, Neuroscience | |
|
Thomas Tull
Angel
|
2 | United States | Series A, Series C, Series B | Artificial Intelligence, Software, Machine Learning | $12M–$320M |
|
CJ Reim
Angel
|
2 | United States | Series A, Seed, Series D | SaaS, Robotics, E-Commerce | $3.7M–$150M |
|
Avichal Garg
Angel
|
2 | United States, Canada, Mexico | Seed, Series A | Software, Blockchain, Internet | |
|
Mei Z.
Angel
|
2 | United States, United Kingdom, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1M–$156M |
|
David R. Walt
Angel
|
2 | United States | Seed, Series A, Series B | Biotechnology, Genetics, Life Science | |
|
Joshua Elkington
Angel
|
2 | United States | Seed | Biopharma, Life Science, Biotechnology | $2.6M–$2.6M |
|
Balaji Srinivasan
Angel
|
2 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $450k–$28M |
|
Nitesh Banta
Angel
|
2 | United States, Canada, India | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$47M |
|
Jonathan Milner
Angel
|
2 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Varsha Rao
Angel
|
2 | United States, India, France | Seed, Series A, Series B | Health Care, Artificial Intelligence, Software | $2M–$63M |
|
Nat Turner
Angel
|
2 | United States, China, Colombia | Seed, Series A, Series B | Health Care, Software, Medical | $1.5M–$36M |
|
Peter Harris
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Health Diagnostics | $2.4M–$5M |
|
Lars Fjeldsoe-Nielsen
Angel
|
2 | United States, United Kingdom, Denmark | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.8M–$125M |
|
Joe Betts-Lacroix
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Pharmaceutical | $3.6M–$4.3M |
|
Brian S. Cohen
Angel
|
2 | United States, Israel | Seed, Series A | Software, SaaS, Mobile | $300k–$12M |
|
Sujay Jaswa
Angel
|
2 | United States, Spain, Germany | Seed, Series B, Series A | Software, Apps, FinTech | $1.8M–$200M |
|
Daniel Schryer
Angel
|
2 | United States, India, Panama | Seed, Series B, Angel | Software, Internet, Mobile | $25k–$50M |
|
Michael Chambers
Angel
|
2 | United States | Series A, Venture - Series Unknown | Biotechnology, Genetics, Life Science | $30M–$55M |
|
Tom X Lee
Angel
|
2 | United States | Seed, Series A, Series B | Health Care, Medical, Artificial Intelligence | $2.3M–$40M |
|
Dmytro Shvets
Angel
|
2 | United States, United Kingdom, Canada | Pre-Seed, Seed, Series A | Artificial Intelligence, Apps, Software | $200k–$11M |
|
Edward Lando
Angel
|
2 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $125k–$37M |
|
Katie Haun
Angel
|
2 | United States, United Kingdom | Seed, Series A | Blockchain, Financial Services, FinTech | $4.5M–$200M |
|
Ankit Jain
Angel
|
2 | United States | Seed, Pre-Seed | Health Care, Medical, Hospital | $75k–$3.5M |
|
Dylan Taylor
Angel
|
1 | United States, Canada, Finland | Seed, Series A | Aerospace, Space Travel, Satellite Communication | |
|
Ali Shaaban
Angel
|
1 | Egypt, United States, Kenya | Series A, Seed, Pre-Seed | Financial Services, FinTech, Banking | |
| Access all 410 angel investors in United States Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Mexico, Norway
Investor stats
- Total investments: 276
- Round size: Seed $500k–$15M; Series A $7M–$36M; Series B $23M–$150M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Seezo — Security design reviews for every feature your company builds. Someday, we will be more active on Twitter
- Neurable — Neurable is a neurotechnology company specializing in developing AI-powered tools for brain signal translation and brain-computer interface technology. Utilizing patented signal processing, developed through research across labs and institutions, and advanced by a scientific and expert product team, its platform enables high-performancebrain-computer interface in everyday devices.
- Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 55
- Round size: Seed $1M–$7M; Pre-Seed $110k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 25
- Round size: Seed $5.4M–$14M; Series A $12M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zanskar — Zanskar Geothermal & Minerals uses custom AI tools and geoscience models to analyze vast amounts of data and pinpoint untapped geothermal hotspots.
- Play Health — Delivering data & AI-driven (peri)menopause care software to improve outcomes today, developing precision medicine infrastructure for tomorrow.
- Dunia Innovation — Catalysing the energy transition.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $10M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 101
- Round size: Seed $190k–$5.2M; Pre-Seed $800k–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Trace — Trace is an orchestration engine that breaks down existing workflows, assigns repetitive tasks to AI agents and routes the rest to the right people.
- Augmend — Create documentation and an AI assistant from any video.
Jeff Hammerbacher - Partner & Co-Founder @ Techammer
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lamin — Open data platform for traceable multimodal AI. Query, trace, and govern data with a lineage-native lakehouse for files, tables, arrays, ontologies, and notes.
- Ridge AI — Ridge AI makes it fast and easy for SaaS companies to prove value inside their product.
- United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 185
- Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$73M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- SolveAI —
- Rowspace — Specialized intelligence for investors. Compound your firm's edge. We're hiring!
- Harmattan AI — Building the Future of Autonomous Warfare.
Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Ghana
Investor stats
- Total investments: 186
- Round size: Seed $1.2M–$10M; Series A $10M–$50M; Series B $17M–$100M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
- Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
- Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 151
- Round size: Seed $1.3M–$8M; Pre-Seed $1.5M–$5.6M; Series A $5.3M–$30M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Mason America, Inc. — Mason is the device innovation platform for product leaders who dare to deliver the next innovation in their field.
- Cara — Cara is a domain-specific AI platform purpose-built for insurance—a modular system that enables agencies, brokerages, and MGAs to automate servicing, accelerate sales, and scale operations with a 24/7 digital workforce.
- Triangle Health — Triangle Health is a software company that uses artificial intelligence to analyze medical documents.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Russian Federation
Investor stats
- Total investments: 72
- Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Equity Crowdfunding, Series A
- Geography: United States, Canada, Algeria
Investor stats
- Total investments: 60
- Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 72
- Round size: Seed $1.4M–$7.6M; Pre-Seed $1.5M–$2.3M; Series A $3M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
- Crosby — The AI Law Firm Built for Execution. Lawyer-assisted AI to review MSAs, DPAs and NDAs in under an hour.
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Alec Nielsen is the Founder & CEO at Asimov.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Germany
Investor stats
- Total investments: 6
- Round size: Seed $3M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
- Lamin — Open data platform for traceable multimodal AI. Query, trace, and govern data with a lineage-native lakehouse for files, tables, arrays, ontologies, and notes.
- General Proximity — The next generation of induced-proximity medicines. We're here to put a dent in the universe.
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more...Investment focus
- Industry: Life Science, Chemical, Genetics
- Stage:Seed, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Robin Lingg - Chairman of the Board of Directors @ DeinDeal
Show more...Investment focus
- Industry: News, Life Science, Machine Learning
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $1.5M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AppliedXL — Applied XL is an information company that uses machine learning and editorial algorithms to anticipate disruptions to the health of people, places and planet.
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Angel
- Geography: United States, Singapore
Investor stats
- Total investments: 11
- Round size: Seed $4.5M–$7M; Series A $12M–$30M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- SmartWorx — Enterprise no-code platform. Build governed, AI-powered enterprise applications without writing a single line of code. Not bolted on. Built in.
- GlucoTrack — GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices. It has developed a medical device that measures glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic.
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States
Investor stats
- Total investments: 33
- Round size: Seed $2.5M–$5.6M; Series A $5M–$16M; Series B $35M–$50M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Sridhar Iyengar is based out of Cambridge, Massachusetts, and is the Founder, CEO, Chief Strategy & Technology Officer, and Chairman of Elemental Machines. Sridhar previously worked at Misfit Wearables as Founder, CTO, and Director. Sridhar Iyengar attended the University of Cambridge.
Show more...Investment focus
- Industry: B2B, Events, Travel
- Stage:Seed, Angel, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 7
- Round size: Seed $470k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stedi — Stedi is the only programmable healthcare clearinghouse. We offer modern, AI-ready APIs for eligibility checks, claims, transaction enrollment, and more.
- Fuel — Keunggulan Rumtar88slot ada pada akses stabil, tampilan mobile friendly, keamanan, dan layanan profesional untuk pengalaman slot online nyaman.
- Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
Patrick Collison is a CEO of Stripe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series C
- Geography: United States, United Kingdom, Ireland
Investor stats
- Total investments: 72
- Round size: Seed $2.7M–$13M; Series A $10M–$105M; Series C $20M–$170M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Centivax — Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
- The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
- SendCutSend — SendCutSend is an online custom manufacturing service specializing in rapid, high-precision sheet metal fabrication and CNC machining. Customers simply upload their digital design files to get professional-grade parts manufactured and shipped to their door, with turnaround times as fast as 24 hours.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jay Zaveri is based out of Menlo Park, California, and is the President and Board of Directors of Aether Bio and Founder and Partner of Natural Capital.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 70
- Round size: Seed $1M–$4M; Series A $3M–$25M; Series B $25M–$6B
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
- Litterati — Litterati is an app that encourages users to pick up and track litter.The app plans to let users join groups, so that schools, clubs, and other communities can track their collective efforts rather than having to go solo. It will also introduce maps, so litter-pickers can see what else is being picked up in their neighborhoods.
- Kingdom — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Japan
Investor stats
- Total investments: 104
- Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Moonlake AI — Vibe code games and worlds into existence.
- Belfort — Enabling Fully Homomorphic Encryption through Hardware Acceleration
- Periodic Labs — From bits to atoms.
James Hong
Show more...Investment focus
- Industry: E-Commerce, Mobile, Internet
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 29
- Round size: Seed $100k–$3.7M; Angel $975k–$3M; Series A $1M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 259
- Round size: Seed $2M–$17M; Series A $9.5M–$50M; Series B $27M–$117M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
- Harvey — Harvey is an artificial intelligence technology service provider.
- Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Aiden Ross
Show more...Investment focus
- Industry: Consulting, Life Science, Neuroscience
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Spike Neuro — We seek to provide equitable access to development resources so all researchers have the opportunity to impact the neuroscience community.
Thomas Tull is the founder, chairman, and chief executive officer of Legendary Entertainment, a media company that produces content for mainstream audiences.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Series C, Series B
- Geography: United States
Investor stats
- Total investments: 43
- Round size: Series A $12M–$250M; Series B $40M–$163M; Series C $50M–$320M
- Lead/follow: 51% lead, 49% follow
Portfolio highlights
- Slate Auto — We built it. You make it. A simple, affordable personalized truck (or SUV, your call). Put down a deposit today and lock in your delivery timing.
- Re:Build — Re:Build Manufacturing helps organizations move from concept to full-scale production by uniting design, engineering, and manufacturing to bring innovative products to market.
- Colossal Biosciences — The science of genetics. The business of discovery.
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more...Investment focus
- Industry: SaaS, Robotics, E-Commerce
- Stage:Series A, Seed, Series D
- Geography: United States
Investor stats
- Total investments: 18
- Round size: Seed $3.7M–$9.7M; Series A $5M–$27M; Series D $80M–$150M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Industry: Software, Blockchain, Internet
- Stage:Seed, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 32
- Round size: Seed $4M–$101M; Pre-Seed $1M–$11M; Series A $17M–$156M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FlyMy.AI — Real-time AI cloud
- Medra AI — Building robotics to accelerate scientific breakthroughs. At Medra, our mission is to automate repetitive wetlab tasks so scientists can more easily collect data and run the experiments needed to make groundbreaking scientific discoveries.
- Periodic Labs — From bits to atoms.
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Joshua Elkington
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.6M–$2.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 271
- Round size: Seed $2.3M–$15M; Pre-Seed $450k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
Nitesh Banta is the Co-Founder & CEO at B12.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 111
- Round size: Seed $1.3M–$16M; Pre-Seed $500k–$2.5M; Series A $6.5M–$47M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Pelgo — Pelgo is a startup that provides AI-powered career transition services. For employees coming out of layoffs, young grads just entering the job market, or full-time professionals trying to adjust to a developing AI-driven economy, its tools, along with human advisors, help onboarding, transition, and reskilling.
- howie — Howie is an AI calendar secretary for email, SMS, iMessage, Gmail, and Google Calendar. He books meetings, protects focus time, follows up, and handles reminders.
- Self Protocol — Self is spearheading a secure, human-first internet by allowing users to verify their identities while maintaining their privacy. Self Protocol is an identity and proof-of-humanity solution that uses zero-knowledge technology to confirm personhood and distinctive traits, like age and nationality, without revealing private information.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 62
- Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Varsha Rao is an Executive Partner at Flare Capital Partners, former Head of Global Operations at Airbnb, CEO of Nurx and COO at Clover Health. She was the Co-Founder of Eve.com. Rao received her BS/BA in Economics/Math from the University of Pennsylvania and an MBA from Harvard Business School.She is an active angel investors withsuccessful investments in AI-Infra, Healthcare, Vertical AI, Consumer Tech and more.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Series A, Series B
- Geography: United States, India, France
Investor stats
- Total investments: 60
- Round size: Seed $2M–$15M; Series A $5M–$46M; Series B $9.4M–$63M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Alex AI — Alex is the AI recruiter that puts sourcing, screening, and scheduling on autopilot. Fast-track vetting so you interview the best in days.
- TextQL — TextQL is you personal virtual data analyst, built for enterprise and powered by AI. Ask in natural english and Ana can build insightful analysis, stunning charts, and powerful models, all with enterprise-grade security.
- Raindrop — Monitor your AI Agent the right way. Get alerted when your agent fails in production, trace exactly what went wrong, and prove your fix worked.
Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, China, Colombia
Investor stats
- Total investments: 78
- Round size: Seed $1.5M–$6.3M; Series A $3M–$25M; Series B $5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Collectors — The infrastructure that powers trust, security, and opportunity in collectibles.
- Iterative Health — Iterative Health is a healthcare technology and services company that focuses on accelerating clinical research to improve patient outcomes through innovative approaches. The company transforms gastrointestinal (GI) care by utilizing AI-driven clinical trials and diagnostics, significantly enhancing access to vital treatments.
Peter Harris
Show more...Investment focus
- Industry: Life Science, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.4M–$5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Denmark
Investor stats
- Total investments: 98
- Round size: Seed $1.8M–$10M; Series A $6.4M–$48M; Series B $15M–$125M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Blue — An Operating System for your Personal Health. Join the waitlist here.
- UrbanKisaan — UrbanKisaan builds vertical farms in India and sells the produce directly to consumers via subscription based app. The farms create a positive change at every step from seed to store ensuring quality and traceability. They grow fresh veggies locally produced which are grown without using soil using 95% less water. It aims to create a sustainablefuture for farming and feed the world in a way that is good for both people and the planet.It was founded in 2017 and is headquartered in Hyderabad, Andhra Pradesh, India.
- Colossal Biosciences — The science of genetics. The business of discovery.
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $3.6M–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
- Spring Discovery — Giving Scientists AI Superpowers
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 46
- Round size: Seed $300k–$2.5M; Series A $1.2M–$12M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
- Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more...Investment focus
- Industry: Software, Apps, FinTech
- Stage:Seed, Series B, Series A
- Geography: United States, Spain, Germany
Investor stats
- Total investments: 30
- Round size: Seed $1.8M–$10M; Series A $11M–$200M; Series B $15M–$85M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
- point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
- PlayerZero — PlayerZero builds a production world model so SRE, QA, and support resolve incidents, prevent defects, and close tickets faster. Trusted by Verizon & Zuora.
Dan Schryer was formerly CEO of DCI Data Centers, a Blackstone backed technology real estate company. Together with Guru Gowrappan, formerly CEO of Verizon Media, he co-founded Bali Venture Partners, LLC to invest in seed and growth stage debt and equity opportunities.
Show more...Investment focus
- Industry: Software, Internet, Mobile
- Stage:Seed, Series B, Angel
- Geography: United States, India, Panama
Investor stats
- Total investments: 35
- Round size: Seed $25k–$1M; Angel $75k–$670k; Series B $150k–$50M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- 54gene — 54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research iscaucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
- Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
- SOS Hydration — Rescue yourself from dehydration with SOS, doctor formulated rapid hydration with 80x less sugar than sports drinks and only 3g carbs and 10 calories.
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Series A, Venture - Series Unknown
- Geography: United States
Investor stats
- Total investments: 3
- Round size: Series A $30M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
- Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
- 64x Bio — A comprehensive platform and product suite for advanced therapeutics.
Tom X Lee is the CEO of Galileo. Took up BS, Biology at Yale University.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 18
- Round size: Seed $2.3M–$9.5M; Series A $10M–$22M; Series B $26M–$40M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Allara — Allara is your all-in-one virtual care team for hormonal, metabolic & gynecological conditions such as PCOS and Endometriosis.
- Systole Health — Join Systole Health and take control of your heart health. Our personalized group virtual care combines expert-led medical treatment with the power of community support.
- Parakeet Health — Parakeet Health is a AI contact center agent for healthcare practices.
Tech entrepreneur focused on on-device AI infrastructure. Currently building Mirai, on-device layer for AI model makers & products. Formerly co-founder & CEO of Reface, scaling consumer AI apps to 300M users. Board member at Endeavor Ukraine, a16z Scout, angel investor in startups including ElevenLabs, Dapper Labs, and others.
Show more...Investment focus
- Industry: Artificial Intelligence, Apps, Software
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 11
- Round size: Seed $1M–$11M; Pre-Seed $200k–$1.4M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- GRAI — GRAI is an AI music research company building interactive music products
- Yope — Salo is a discussion platform that erases the borders for people with diverse opinions to let anyone speak up and be heard.
- DreamApp — Unlock the meaning of your dreams with DreamApp's dream interpretation. Discover the symbolism behind common dreams with our dream dictionary. Explore Now!
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 478
- Round size: Seed $975k–$7M; Pre-Seed $125k–$3.4M; Series A $5.5M–$37M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera - AI CAPTCHA That Knows You're Human
- Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
- Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Katie is the founder and CEO of Haun Ventures, a Silicon Valley venture fund that manages billions in investments across frontier technologies including blockchain and digital assets. The firm’s institutional investors are major sovereign wealth funds, endowments, foundations, financial institutions, and other global organizations.She has servedas a board member of several high-growth technology companies. As Coinbase’s first independent director, she was an early architect of company’s global regulatory strategy, serving through its direct listing and subsequent growth as a publicly traded company. During her tenure from 2017 to 2024, she held several positions including Chair of the Nomination and Governance Committee, Chair of the Audit and Risk Committee, and member of the Compensation Committee.Katie joined Andreessen Horowitz as a General Partner in 2018. There, she co-led their crypto franchise, building a team and investing out of three successive funds with billions under management, generating significant realized returns for institutional investors.Before her venture career, Katie spent over a decade as a federal prosecutor with the U.S. Department of Justice. She secured successful jury verdicts in every case she tried and led high-profile prosecutions related to the Silk Road task force, the 2012 Hells Angels murder trial, and the Nuestra Familia prison gang RICO takedown. She also led cyber, corporate, and violent crime investigations in partnership with the FBI, Homeland Security, SEC, and Treasury. At DOJ headquarters, she held senior leadership positions in the National Security Division and later the Attorney General’s office where her portfolio covered antitrust, tax, and national security matters. Katie represented DOJ on both CFIUS and the FBI’s Undercover Review Committee, that approved significant undercover operations.Katie has been profiled by Bloomberg, Fortune, The New York Times, and CNBC and was named one of Bloomberg BusinessWeek’s 50 Most Influential in 2022.
Show more...Investment focus
- Industry: Blockchain, Financial Services, FinTech
- Stage:Seed, Series A
- Geography: United States, United Kingdom
Investor stats
- Total investments: 22
- Round size: Seed $4.5M–$200M; Series A $15M–$55M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
- Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
- Coinbase Token Manager — LiquiFi helps crypto companies automate token vesting, issue token grants in compliance, and manage their token cap table.
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 6
- Round size: Seed $75k–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
Dylan Taylor is a global business leader, commercial astronaut, thought leader and philanthropist. Currently, Dylan serves as Chairman & CEO of Voyager Space, a multi-national space exploration firm focused on building the next generation of space infrastructure for NASA and other global space agencies.Dylan has been recognized by HarvardUniversity, SpaceNews, the BBC, the Financial Times, Pitchbook, CNBC, CNN and others as having played a seminal role in the growth of the private space industry. As an early-stage investor in more than 50 emerging space ventures, including Axiom, Kepler, York, Astrobotic, LeoLabs, Relativity, and Planet, Dylan is widely considered the most active private space investor in the world.Dylan’s technical background, global business experience and unbridled passion for space make him a unique figure within his industry. As a thought leader and futurist, he has written many popular pieces on the future of the space industry for Forbes, FastCompany, Newsweek, SpaceNews, The Space Review, and Space.com. As a speaker, Dylan has keynoted many of the major space conferences around the world and has appeared regularly on Bloomberg, Fox Business, and CNBC.Dylan has extensive global business experience as both a board director and CEO in several industries, including advanced electronics, finance and real estate. He previously served as a Director for UMB Bank, a Fortune 500 company based in Kansas City and as a mutual fund director for the Jackson Funds where he oversaw assets of $8B across 130 distinct funds. He has also served in the roles of CEO, President and Board Director for multinational companies like Prudential PLC, Honeywell, Colliers and Jones Lang LaSalle. Dylan was recognized as a Fortune 1000 CEO with P&L responsibility in excess of $3B and operations encompassing 15,000 employees in over 60 countries. In addition, Dylan has participated in 4 IPOs over the course of his career. Dylan is a leading advocate of space manufacturing and the utilization of in-space resources to further space exploration and settlement. In 2017, he became the first private citizen to manufacture an item in space when the gravity meter he co-designed and commissioned was 3D printed on the International Space Station. The historic item is now housed in the Museum of Science and Industry in Chicago.Dylan is an explorer of note. On December 11th, 2021 Dylan became just the 606th human to go to space as part of the crew of Blue Origin’s NewShepard Mission 19. Accordingly, Dylan earned his commercial astronaut wings with the FAA and his universal astronaut wings from the Association of Space Explorers.He is also one of only a handful of humans to have descended to the deepest part of the world’s oceans, Challenger Deep in the Mariana Trench as part of the Limiting Factor Expedition in July of 2022. In that mission, Dylan descended with pilot Victor Vescovo to a depth in excess of 10,800 meters (35,500 feet) into an area of the Mariana Trench that had never been visited by humans. Dylan is the youngest human to have been to the deepest part of the world’s oceans and crossed the Karman line into Space. Dylan has been a member of the Explorers Club since 2014.Dylan maintains an extensive philanthropic impact on the space industry. In 2017, Dylan founded the nonprofit and social movement, Space for Humanity, which seeks to democratize space exploration and develop solutions to global issues through the scope of human awareness to help solve the world’s most intractable problems. Space for Humanity has successfully sent two citizen astronauts to space via Blue Origin including both the first Mexican-born woman (Katya Echazareta), and first African-born woman (Sara Sabry). Building upon his passion and support for the space industry, Dylan serves as a strategic advisor for both the Archmission and the Human Spaceflight Program and is a co-founding patron of the Commercial Spaceflight Federation, which promotes the growth of commercial space activity. Additionally, he is also a leading benefactor to the Brooke Owens Fellowship, Patti Grace Smith Fellowship and Mission: Astro Access.Dylan is the founder and Chairman of Multiverse Media, an integrated global media company focused on science and technology, with an emphasis on space. Multiverse is the parent company of the popular space philosophy website 2211.world as well as the Ad Astra Dinners, a Jeffersonian-style dinner series featuring some of the world’s leading influencers discussing the future of humanity in space. Another subsidiary of Multiverse Media, Multiverse Publishing, publishes books by leading authors including Frank White, Isaac Asimov and Gerard K. O’Neill. Multiverse is also the executive producer of the documentary film, The High Frontier and the forthcoming film, Fortitude. For his influence as a global leader and his commitment to creating a positive impact on the world, Dylan has been honored with numerous personal and professional accolades in recent years. The World Economic Forum recognized Dylan as a Young Global Leader in 2011 and a full member of the World Economic Forum in 2014. That same year he was named a Henry Crown Fellow of the Aspen Institute. In 2020, Dylan was recognized by the Commercial Spaceflight Federation with their top honor for business and finance, following in the footsteps of 2019’s inaugural winner, the late Paul Allen and subsequent winners Jeff Bezos and Elon Musk.Dylan Taylor earned an MBA in Finance and Strategy from the Booth School of Business at University of Chicago and holds a BS in Engineering from the honors college at the University of Arizona, where he graduated Tau Beta Pi and in 2018 was named Alumnus of the year. He is also a graduate of the Global Leadership and Public Policy for the 21st Century program at Harvard University.Dylan and his family reside in Denver, Colorado where he is active locally with Colorado Concern and the Colorado Spaceport. In his spare time, Dylan enjoys hiking, competing in triathlons and spending time outdoors. As a weekend warrior athlete, Dylan has more than 25 top ten finishes and 25 age group wins to his credit, and he regularly interviews world class athletes whom have shown extraordinary resilience as the host of the Legendary Podcast. He is married to legal expert, consultant and author Gabrielle V. Taylor with whom he has two teenage daughters.
Show more...Investment focus
- Industry: Aerospace, Space Travel, Satellite Communication
- Stage:Seed, Series A
- Geography: United States, Canada, Finland
Investor stats
- Total investments: 60
- Lead/follow: no public data
Portfolio highlights
- Xplore — Xplore is flying commercial missions in Earth orbits with their XCRAFT™, and they invite you to join us. They take civilian, commercial and national security payloads to their desired orbit around Earth for their science or reconnaissance missions.
- LeoLabs — LeoLabs' network of ground-based, phased array radars produces high-resolution data on objects in LEO, supporting satellite service industries.
- Space Forge — Space Forge make super materials in space that cannot be made on earth.
Ali Shaaban has been a pioneer in the digital advertising and communications industry for more than 18 years, founding the award-winning full-fledged creative digital agency Icon Creations back in 2003 when the industry was at its infancy stage. Since then, Ali Shaaban has built strong long-term relationships and a strategic network with most ofthe leading automotive brands in Egypt and the Middle East, where he established a solid track record of delivering top-notch digital products & services that stood the test of time. Driven by passion for excellence and an always-on personalized approach to satisfying his partners, Ali Shaaban is the quintessential digital partner to have on your side in the automotive industry today.His automotive portfolio includes Alfa Romeo, Bentley, BMW, Castrol, Citroën, Ferrari, Fiat, Ford, Hyundai, JAC, Jaguar, Jeep, KIA, Land Rover, Maserati, Mazda, MINI, Mitsubishi, Nissan, Peugeot, Pirelli, Renault, Seat, Subaru, Toyota, Volkswagen and more. Aside from being a digital pioneer, Ali Shaaban is also an angel investor and serial supporter of emerging innovative startups and fresh business ideas, venturing into several sectors to contribute in making a sustainable impact on the local and regional economies. His latest investments have tapped into the Fintech sector with rising companies such as Paynas (https://Paynas.com), Oxygen (https://oxygen.us/), Dfin Holding (https://www.dfinholding.com/) , and Kiwe wallet (https://kiweapp.com/) as well as the Media and AI sector with Speakol (https://speakol.com/) , NU Digital Awards (https://nudigitalawards.com/) and Nanotronics (https://nanotronics.co/ ).Ali Shaaban believes in always taking the next step forward in his extensive career, and using his core values and commanding personality as motivation, he has paved an impressive path over the years that will certainly lead towards an even more diverse and fruitful future.
Show more...Investment focus
- Industry: Financial Services, FinTech, Banking
- Stage:Series A, Seed, Pre-Seed
- Geography: Egypt, United States, Kenya
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- ImaliPay — ImaliPay is a financial health platform offering financial products to freelancers and blue collar gig workers in partnership with gig platforms.
- QuadriBot — QuadriBot is an engineering company specializing in the design and development of electronics and automation technology, real-time systems and the development of IT and electronic solutions around smart transportation issues. We focus on robotics and autonomous vehicles as well as any mobile platfo.
- Nanotronics Imaging — At Nanotronics we provide customized solutions for automated optical inspection, process control, and security. Learn more about what we can do for you.
Life Science Angel investor funding in United States at a glance
Stats across 287 deals from 410 investors.
Access all 410 angel investors in United States Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 410 angel investors investing in United States Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!